Trials / Sponsors / Tibotec, Inc
Tibotec, Inc
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Study of the Once Daily Combination of Etravirine and Darunavir/Ritonavir As Dual Therapy in Early Treatment Human Immunodeficiency Virus (HIV) | Phase 2 | 2010-05-01 |
| Completed | A Phase I, Open-label Trial to Explore the Pharmacokinetics, Safety and Tolerability of TMC278 (Rilpivirine) 2 HIV | Phase 1 | 2010-01-01 |
| Completed | Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Ata HIV | Phase 4 | 2008-10-01 |
| Completed | A Study to Evaluate the Pharmacokinetic Profile (How the Body Absorbs, Distributes, Metabolizes and Eliminates HIV-1 Infection | Phase 2 | 2008-01-01 |
| Completed | Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With HIV | Phase 3 | 2007-05-01 |
| Completed | GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gend HIV, Infectious | Phase 3 | 2006-11-01 |